Washington, DC, United States of America

Allan L Goldstein

This inventor holds 24 USPTO granted patents and 10 published patent applications, plus 3 CIPO patents and 2 EPO patents, primarily in Peptide Therapeutics. Top assignees: Regenerx Biopharmaceuticals, Inc., The George Washington University, Hoffmann-La Roche Inc.. Active years: 1977-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Allan L Goldstein. Retrieved from https://idiyas.com/inventor/allan-l-goldstein

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 24 (Patent Applications = 10)

% Patents Active = 79.2

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 2.1

ph-index = 9

Forward Citations = 228(Granted Patents)

Location History:

Galveston, TX (US) (1977 - 1978)
Bethesda, MD (US) (1996)
Bethedsa, MD (US) (1997)
Washington, DC (US) (1981 - 2018)

Company Filing History:

9 out of 12

Regenerx Biopharmaceuticals, Inc.

patents

7 out of 284

The George Washington University

patents

3 out of 5,027

Hoffmann-La Roche Inc.

patents

4. 3 out of 5

Viral Technologies, Inc.

patents

5. 2 out of 5,644

The University of Texas System

patents

6. 1 out of 514

Albert Einstein College of Medicine

patents

7. 1 out of 28

The United States of America as Represented by the Secretary of Health

patents

8. 1 out of 3,699

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

where one patent can have more than one assignee

Years Active: 1977-2018

Loading Chart...

Areas of Expertise:

Peptide Compositions

Thymosin Beta 4

Inflammation Treatment

Tissue Repair

Extracellular Matrix

Diagnostic Methods

Myocardial Event

Neurodegenerative Diseases

Skin Treatment

Wound Repair

HIV Peptides

Radioimmunoassay

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10004785 - LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilized (2018-06-26),

2. 9821030 - LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilized (2017-11-21),

3. 9585941 - Eye drop formulation (2017-03-07),

4. 9056087 - Methods of healing or preventing inflammation, damage and other changes that occur prior to, during or immediately after a myocardial event with thymosin beta 4, analogues, isoforms and other derivatives (2015-06-16),

5. 8716215 - Method of treating or preventing tissue deterioration, injury or damage due to a neuro-, muscular- or neuro-muscular-degenerative disease, or restore tissue adversely affected by said disease (2014-05-06),

6. 8399609 - Treating or preventing extracellular matrix build-up (2013-03-19),

7. 8399412 - Method of treating or preventing tissue deterioration, injury or damage due to periodontal disease or disease of oral mucosa, and/or downregulating NF-kappabeta or supressing NF-kappabeta-mediated actions (2013-03-19),

8. 8383576 - LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilized (2013-02-26),

9. 8143218 - Treatment of skin, and wound repair, with thymosin beta 4 (2012-03-27),

10. 7268118 - Thymosin β4 compositions (2007-09-11),

11. 6197751 - Thymosin &agr;1 promotes tissue repair, angiogenesis and cell migration (2001-03-06),

12. 5702707 - Diagnostic method and test kit for the serological detection of the AIDS (1997-12-30),

13. 5665536 - Diagnastic method and test kit for the serological detection of the AIDS (1997-09-09),

14. 5593964 - Method of treating septic shock by preventing actin polymerization (1997-01-14),

15. 5585234 - Treatment of infertile sperm in vitro with thymosin .alpha..sub.1 to (1996-12-17),

Title: Innovator Spotlight: Allan L Goldstein - Pioneering Peptide Compositions

Introduction:

Allan L Goldstein is a distinguished inventor based in Washington, DC, with a remarkable portfolio of 24 patents to his name. His groundbreaking work in peptide compositions has garnered acclaim in the field of biopharmaceuticals and beyond.

Latest Patents:

Recently, Allan L Goldstein secured patents for his innovative LKKTET and LKKTNT peptide compositions. These compositions, whether lyophilized or in a form capable of being lyophilized, contain peptide agents with specific amino acid sequences. The inclusion of stabilizing agents ensures the integrity of the composition, making it a significant advancement in the industry.

Career Highlights:

Throughout his career, Allan L Goldstein has made significant contributions to the field of biopharmaceuticals. He has been associated with esteemed organizations such as Regenerx Biopharmaceuticals, Inc. and The George Washington University, where his expertise and innovative spirit have driven research and development efforts to new heights.

Collaborations:

An inventor of Allan L Goldstein's caliber does not work in isolation. He has collaborated with talented individuals in the field, including coworkers Teresa L Low and Gabriel Sosne. Together, they have combined their knowledge and skills to push the boundaries of scientific innovation.

Conclusion:

Allan L Goldstein's passion for invention and his dedication to advancing peptide compositions have solidified his reputation as a trailblazer in the industry. His patented creations stand as a testament to his ingenuity and commitment to shaping the future of biopharmaceuticals. We look forward to witnessing more groundbreaking developments from this visionary inventor.

Profile summary based on public USPTO records.